Barclays PLC Has $6.63 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Barclays PLC lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 13.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 349,112 shares of the medical instruments supplier's stock after buying an additional 42,303 shares during the quarter. Barclays PLC owned about 0.18% of DENTSPLY SIRONA worth $6,625,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Nordea Investment Management AB grew its position in shares of DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock worth $4,754,000 after buying an additional 178,639 shares during the period. JPMorgan Chase & Co. grew its holdings in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after purchasing an additional 1,244,326 shares during the period. Bank of New York Mellon Corp grew its holdings in DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after purchasing an additional 523,692 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in DENTSPLY SIRONA by 1.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after purchasing an additional 35,360 shares during the period. Finally, Canvas Wealth Advisors LLC grew its holdings in DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier's stock valued at $6,245,000 after purchasing an additional 182,234 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $0.05 during mid-day trading on Wednesday, hitting $13.90. 3,680,447 shares of the company were exchanged, compared to its average volume of 2,976,561. The business has a 50 day simple moving average of $14.79 and a 200-day simple moving average of $18.11. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $2.77 billion, a PE ratio of -6.71, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $30.78.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.60%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.52% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on XRAY. Mizuho cut their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Thursday, March 13th. Piper Sandler cut their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Finally, Evercore ISI reiterated an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Thirteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus price target of $21.25.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.